Thinking of joining a study?

Register your interest

Become a volunteer?

NCT04275557 | RECRUITING | Pancreatic Cancer

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Brief Summary:

The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of information obtained from blood, tissue, medical images, surveys and information from routine care to develop noninvasive diagnostic approaches that could be used as decision-making tools to effectively personalize clinical care.

Condition or disease

Pancreatic Cancer

Pancreatic Cyst

Intervention/treatment

Blood Sample collection

Tissue sample collection

Data collection

Study Type : OBSERVATIONAL
Estimated Enrollment : 1174 participants
Official Title : Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas and Uncover Hidden Biology
Actual Study Start Date : 2020-02-18
Estimated Primary Completion Date : 2026-06
Estimated Study Completion Date : 2027-06

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Individuals who present to the GI clinic, surgery, or endoscopy at Moffitt, Florida Research Institute (FRI), or UM with a clinical suspicion for (or diagnosis of) a pancreatic lesion, cyst, mass, cancer, or pancreatitis based on symptoms, imaging, or blood-work and has not had any treatment involving their pancreas.
  • * Able to understand and voluntarily sign the informed consent.
  • * Willing to complete study questionnaire(s) and donate medical images and/or biological specimens (including blood, cystic fluid, and/or tissue) obtained at the time of standard of care procedures (biopsy, surgery, and venipuncture) after signing the informed consent document
Exclusion Criteria
  • * No suspicion or diagnosis of a pancreatic lesion, cyst, mass, cancer, or pancreatitis.
  • * Has a diagnosis of a pancreatic lesion, cyst, mass, cancer, or pancreatitis and has already undergone treatment involving the pancreas (which may involve surgery, chemo- or immuno-therapy, and/or radiation).
  • * Unable to provide informed consent.
  • * Unwilling to complete study questionnaire(s) and/or donate biological specimens or images.
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Location Details

NCT04275557

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Florida

Florida Research Institute (FRI)

Lakewood Rch, florida, United States, 34211

RECRUITING

United States, Florida

Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital

Miami, florida, United States, 33136

RECRUITING

United States, Florida

Moffitt Cancer Center

Tampa, florida, United States, 33612